Syndax Pharmaceuticals, Inc. (SNDX)
17.70
+0.74
(+4.36%)
USD |
NASDAQ |
Jun 09, 16:00
17.70
0.00 (0.00%)
After-Hours: 16:28
Syndax Pharmaceuticals Total Liabilities (Quarterly) : 431.05M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 10.83B |
| Celldex Therapeutics, Inc. | 55.03M |
| Viridian Therapeutics, Inc. | 153.01M |
| Ardelyx, Inc. | 355.88M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 472.67M |
| Shareholders Equity (Quarterly) | 41.62M |
| Debt to Equity Ratio | 8.298 |
| Current Ratio | 5.468 |
| Net Debt Paydown Yield | 0.00% |